Spyre Therapeutics Inc (SYRE)

Überblick Nachrichten Preisverlauf Financials Forum Prognose

Finanzdaten der Spyre Therapeutics Inc-Aktie (SYRE)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2024-03-31
Periodenlänge	3 Monate
Revenues
Operating Expenses
Operating Income/Loss
Nonoperating Income/Loss
Income/Loss From Continuing Operations Before Tax
Income Tax Expense/Benefit
Income/Loss From Continuing Operations After Tax
Net Income/Loss
Preferred Stock Dividends And Other Adjustments
Attributable To Noncontrolling Interest
Basic Average Shares
Diluted Average Shares
Basic Earnings Per Share
Diluted Earnings Per Share
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic

BMRN

$67.48

1.23%

INSM

$73.33

0.15%

RPRX

$31.79

1.63%

SMMT

$18.91

7.58%

BNTX

$92.01

1.40%

ONC

$264.32

3.81%